Evotec (OTCMKTS:EVTCY) Sets New 52-Week Low - Here's Why

Evotec SE (OTCMKTS:EVTCY - Get Free Report)'s stock price hit a new 52-week low on Monday . The stock traded as low as $3.16 and last traded at $3.17, with a volume of 96647 shares traded. The stock had previously closed at $3.22.

Evotec Stock Down 1.6 %

The company has a market capitalization of $1.05 billion, a PE ratio of 7.85 and a beta of 0.98. The business's 50-day simple moving average is $3.36 and its 200-day simple moving average is $4.58. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.